Ecuador vs Western Pacific (WHO region): New cases tested for RR-/MDR-TB
Ecuador
100.0%
in 2024
Western Pacific (WHO region)
89.0%
in 2024
Ecuador rank
1st
Western Pacific (WHO region) rank
2nd
New cases tested for RR-/MDR-TB over time
- Ecuador
- Western Pacific (WHO region)
How they compare
Ecuador currently reports 100.0% against 89.0% in Western Pacific (WHO region), a difference of 11.0%.
That makes Ecuador's figure about 1.1 times Western Pacific (WHO region)'s.
The two have swapped places 4 times across 16 shared years of data; in 2005 it was Ecuador ahead.
Ecuador ranks 1st and Western Pacific (WHO region) ranks 2nd of 192 countries.
Ecuador has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Ecuador | Western Pacific (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.4% | 1.3% | 2.1% | Ecuador |
| 2010s | 21.7% | 20.4% | 1.3% | Ecuador |
| 2020s | 95.8% | 83.2% | 12.6% | Ecuador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Ecuador or Western Pacific (WHO region)?
- Ecuador, at 100.0% against 89.0% in Western Pacific (WHO region) as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Ecuador and Western Pacific (WHO region)?
- 11.0%, with Ecuador ahead.
- How many years of comparable data are there for Ecuador and Western Pacific (WHO region)?
- 16 years are reported by both, from 2005 to 2024.
- How do Ecuador and Western Pacific (WHO region) rank globally for new cases tested for rr-/mdr-tb?
- Ecuador ranks 1st and Western Pacific (WHO region) ranks 2nd of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.